Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ru Cat. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Efficient asymmetric Michael addition for pharmaceutical intermediates using novel Ru-diamine complexes. Reduces cost and improves purity for API manufacturing.
Novel ruthenium catalyst recovery method for adamantane polyol manufacturing ensuring cost efficiency and supply chain stability for global buyers.
Patent CN113929584B reveals a one-step hydrogenation route for PACM 70. This breakthrough offers significant supply chain stability and cost reduction in polymer additive manufacturing.
Patent CN112939892A reveals a green Ru-catalyzed route for quetiapine intermediates. Achieve high purity and yield with water as the only byproduct for cost-effective API manufacturing.
Patent CN101891746B details a novel rhodium-free route for meropenem. Discover cost-effective, high-purity carbapenem manufacturing solutions for your supply chain.
Patent CN111170829B details a safer, high-selectivity route for hexamethylindanol using supported Ru catalysts, offering significant cost and safety advantages for fragrance manufacturers.
Patent CN115724813B reveals a green Ru-catalyzed route for FDCA. Offers cost reduction in bio-based polymer manufacturing and high-purity supply chain reliability.
Novel Ru-catalyzed synthesis of trifluoromethyl quinazolinones. High yield, green solvent, excellent antibacterial activity for agrochemical manufacturing.
Patent CN1360574A details a novel route for tricyclic aminoalcohol derivatives featuring asymmetric reduction. This process offers significant cost reduction and improved supply chain reliability for pharmaceutical manufacturing.
Patent CN112300061B details a novel Ru-catalyzed C-H acylation method using amides, offering a cost-effective and scalable route for high-purity pharmaceutical intermediates.
Patent CN102040584A reveals a high-selectivity hydrogenation route for DCH18C6, offering significant cost reduction in specialty chemical manufacturing through simplified purification.
Novel metal-catalyzed synthesis offers mild conditions and high yields for phenyl pyrrolidine intermediates, ensuring supply chain stability and cost efficiency.
Patent CN107892698B details a solvent-free ruthenium catalyzed selective borylation method offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Efficient Ru-catalyzed C-H activation for 5-maleimide chromones. High yield, scalable process for pharmaceutical intermediates. Cost-effective supply chain solution.
Patent CN102942542A details a cost-effective Ru-catalyzed route for 4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid, offering significant supply chain advantages.
Patent CN103626828A details novel ursolic acid modifications enhancing antitumor activity. This report analyzes scalable synthesis routes for reliable pharmaceutical intermediate supply chains.
Patent CN106349295B reveals mild ruthenium catalysis for nitrobenzene reduction offering supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN107417724B reveals a novel Ru-SPO catalyst achieving 99% selectivity. Discover cost-effective solutions for chiral pharmaceutical intermediate manufacturing.
Patent CN1968927B details a novel Ru-catalyzed route for high-purity quinoline intermediates used in bronchodilators, offering significant cost reduction in API manufacturing.
Patent CN106349102B reveals a safe ruthenium-catalyzed route for meta-alkyl azo aromatic compounds, offering significant cost reduction and supply chain reliability for global buyers.